Sulfur burps—belches with a distinctive rotten egg odour—can be an unexpected and unpleasant side effect for some people taking Victoza (liraglutide). Victoza is a GLP-1 receptor agonist used to treat type 2 diabetes by slowing gastric emptying and improving blood glucose control. This delayed stomach emptying, whilst therapeutically beneficial, can alter normal digestive processes and contribute to gastrointestinal symptoms including malodorous burping. Understanding why this occurs, how common it is, and what can be done to manage it helps patients continue their diabetes treatment effectively whilst minimising discomfort. This article explores the connection between Victoza and sulfur burps, offering practical guidance aligned with UK clinical practice.

What Are Sulfur Burps and Why Do They Occur?

Sulfur burps are belches that produce a distinctive smell of rotten eggs or hydrogen sulfide gas. This unpleasant odour occurs when sulfur-containing gases are released from the digestive system through the mouth. Whilst occasional burping is a normal physiological process that helps release swallowed air, sulfur burps indicate the presence of hydrogen sulfide, which forms when certain foods or medications affect digestive processes.

The production of hydrogen sulfide typically occurs in the gastrointestinal tract when bacteria break down sulfur-containing proteins and amino acids. This process happens primarily in the intestines rather than the stomach. Foods rich in sulfur—such as eggs, red meat, dairy products, cruciferous vegetables (broccoli, cauliflower, Brussels sprouts), and certain preservatives—can contribute to this process. When digestion slows or becomes disrupted, these sulfur compounds may have more time to ferment, leading to increased gas production.

Several factors can trigger sulfur burps beyond dietary choices. Gastrointestinal conditions such as gastroenteritis, small intestinal bacterial overgrowth (SIBO), gastro-oesophageal reflux disease (GORD), irritable bowel syndrome (IBS), Helicobacter pylori infection, and giardiasis may all contribute to altered digestive function and increased sulfur gas production. Additionally, certain medications—particularly those that affect gastric motility or alter the gut environment—can influence the likelihood of experiencing this symptom. It's worth noting that oral bacteria can also contribute to sulfurous odours in some cases.

Understanding the underlying mechanism is important when sulfur burps occur alongside new medication use. The symptom itself, whilst unpleasant and socially uncomfortable, is generally not dangerous. However, persistent malodorous burping with other symptoms may indicate changes in digestive function that warrant attention, particularly when associated with other gastrointestinal symptoms such as nausea, bloating, or changes in bowel habits.

Why Does Victoza Cause Sulfur Burps?

Victoza (liraglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus. A different formulation of liraglutide (Saxenda, 3 mg) is licensed for weight management, but Victoza itself is specifically for diabetes treatment. Understanding Victoza's mechanism of action helps explain why gastrointestinal side effects, including sulfur burps, may occur.

The primary mechanism behind sulfur burps with Victoza relates to the drug's effect on gastric emptying. GLP-1 receptor agonists deliberately slow the rate at which food moves from the stomach into the small intestine. This delayed gastric emptying helps regulate post-meal blood glucose levels and promotes satiety, contributing to the medication's therapeutic benefits. However, when food remains in the stomach for extended periods, it may create conditions that contribute to gastrointestinal symptoms, including belching.

Victoza's effect on gastric emptying can alter the normal digestive timeline, potentially leading to changes in how food is processed and gas is produced. While 'sulfur burps' are not specifically listed in the Summary of Product Characteristics (SmPC), they would be consistent with the gastrointestinal effects documented for the medication.

It is important to note that there is no official link suggesting Victoza directly produces sulfur compounds or uniquely targets sulfur metabolism. Rather, the sulfur burps represent a secondary effect of the medication's intended action on the gastrointestinal system. The symptom typically reflects the body's adjustment to altered digestive timing, rather than a toxic or allergic reaction to the medication itself.

The SmPC for Victoza notes that use is not recommended in patients with severe gastrointestinal disease, including gastroparesis, as the medication's effects on gastric emptying could potentially worsen such conditions.

How Common Are Sulfur Burps with Victoza?

Gastrointestinal side effects are among the most frequently reported adverse reactions to Victoza, though the specific symptom of sulfur burps is not separately documented in clinical trials or listed in the Summary of Product Characteristics (SmPC). According to the SmPC approved by the MHRA, nausea and diarrhoea are very common (affecting more than 1 in 10 people), whilst vomiting, dyspepsia, and abdominal pain are common (affecting up to 1 in 10 people). Belching-related symptoms would typically fall under broader categories of gastrointestinal effects.

Clinical trial data and post-marketing surveillance suggest that gastrointestinal symptoms are most pronounced during the initial weeks of treatment and during dose escalation. The majority of patients experience these effects as mild to moderate in severity, and symptoms often diminish as the body adapts to the medication. However, individual experiences vary considerably, with some patients reporting persistent gastrointestinal symptoms throughout treatment.

Anecdotal reports from patient forums suggest that some patients taking GLP-1 receptor agonists do experience sulfur burps, though this specific symptom is not formally tracked in clinical studies. Without systematic data collection, it's difficult to determine how common this particular manifestation might be.

Factors that may influence susceptibility to gastrointestinal symptoms whilst taking Victoza include: rapid dose escalation, high-sulfur diet, pre-existing gastrointestinal conditions, concurrent use of other medications affecting gut motility, and individual variations in gut microbiome composition. Understanding that these side effects, whilst unpleasant, are related to the medication's therapeutic mechanism may help patients persist with treatment whilst implementing management strategies.

Managing Sulfur Burps While Taking Victoza

Several practical strategies can help minimise sulfur burps whilst continuing Victoza treatment. These approaches focus on dietary modifications, eating habits, and lifestyle adjustments that work alongside the medication's effects on digestion.

Dietary modifications represent the first-line approach to managing this symptom:

• Reduce sulfur-rich foods: Temporarily limit consumption of eggs, red meat, dairy products, cruciferous vegetables, garlic, onions, and foods containing sulfite preservatives

• Eat smaller, more frequent meals: This approach works with Victoza's effect on gastric emptying, reducing the volume of food sitting in the stomach

• Avoid carbonated beverages: These increase gas in the digestive system and may exacerbate burping

• Limit fatty and fried foods: High-fat meals slow gastric emptying further, potentially worsening symptoms

• Stay well hydrated: Adequate water intake supports digestive function and may help reduce gas production

Eating habits and timing also play an important role. Eating slowly and chewing food thoroughly aids digestion and reduces swallowed air. According to the SmPC, Victoza can be administered once daily at any time, independent of meals, but the timing should be consistent. Some patients find that selecting a specific time of day helps minimise their symptoms, though this is based on individual experience rather than clinical evidence.

Additional management strategies include:

• Keeping a food and symptom diary to identify specific triggers

• Following the recommended titration schedule—starting with 0.6 mg daily for at least one week, then increasing to 1.2 mg, and potentially to 1.8 mg if needed—which may help reduce gastrointestinal symptoms

• Considering over-the-counter remedies such as simethicone (which helps break up gas bubbles), though always consult your pharmacist or healthcare provider before starting any additional treatments

• Maintaining good oral hygiene as a general health measure, though this has limited evidence specifically for belching

Patients should not discontinue Victoza without medical guidance, as the medication provides important glycaemic control. Most gastrointestinal side effects improve with time and management strategies.

When to Seek Medical Advice About Victoza Side Effects

Whilst sulfur burps alone are generally not a cause for immediate medical concern, certain circumstances warrant prompt contact with your GP, diabetes specialist nurse, or healthcare provider. Understanding when gastrointestinal symptoms indicate a more serious problem is essential for patient safety.

Seek medical advice promptly if you experience:

• Severe or persistent vomiting: This may lead to dehydration and affect blood glucose control, and could indicate gastroparesis (severe delayed gastric emptying)

• Severe abdominal pain: Particularly if constant, persistent, or radiating to the back, as GLP-1 receptor agonists carry a small risk of pancreatitis

• Right upper abdominal pain, fever or jaundice: These may indicate gallbladder problems, which can occur with GLP-1 receptor agonists

• Signs of dehydration: Including dark urine, dizziness, reduced urination, or extreme thirst

• Inability to tolerate food or fluids: This affects both nutrition and diabetes management

• Blood in vomit or stools: This requires immediate medical assessment

• Symptoms of hypoglycaemia: Particularly if taking Victoza alongside sulfonylureas or insulin

For urgent concerns, contact NHS 111 or attend your local A&E department if symptoms are severe.

Routine review is appropriate when:

• Sulfur burps or other gastrointestinal symptoms persist beyond 4–6 weeks despite management strategies

• Symptoms significantly impact quality of life or medication adherence

• You are considering stopping Victoza due to side effects—your healthcare team may suggest alternative approaches or medications

• You develop new symptoms or your diabetes control deteriorates

According to NICE guidance on type 2 diabetes management (NG28), treatment should be individualised, and medication tolerability is an important consideration. Your healthcare provider can assess whether the benefits of Victoza outweigh the side effects in your particular case, or whether alternative GLP-1 receptor agonists or other diabetes medications might be more suitable.

Never adjust your Victoza dose independently, and always inform healthcare professionals about all symptoms you experience. Suspected side effects can be reported directly to the MHRA through the Yellow Card scheme at www.mhra.gov.uk/yellowcard. Open communication with your healthcare team ensures optimal diabetes management whilst addressing troublesome side effects effectively.

Frequently Asked Questions